-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

3675 Distinguishing the Variances in Patient Care between Hematologists and Hospitalists for Individuals with Sickle Cell Disease Hospitalized Due to Vaso-Occlusive Crisis

Program: Oral and Poster Abstracts
Session: 901. Health Services and Quality Improvement - Non-Malignant Conditions: Poster II
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality)
Sunday, December 10, 2023, 6:00 PM-8:00 PM

Maroun Bou Zerdan, MD1*, Stephanie Niforatos, MD1*, Prashanth Ashok Kumar, MBBS2, Alanna Siegenthaler3*, Mulham Ombada4*, Melanie Kirk5*, Andrulisa Jones6*, Bhavya Poudyal7*, Elad Levine1*, Cathy Liu1*, Joseph Repicky8*, Mahinbanu Mammadli9*, Parth Sampat, MBBS1, Mahnoor Sherazi10*, Matthew Ramm4*, Sanjay Rao Gergal Gopalakrishna Rao11*, Habib Layoun12* and Teresa Gentile, MD, PhD13

1SUNY Upstate Medical University Hospital, Syracuse, NY
2Upstate Cancer Center, Division of Hematology/Oncology, SUNY Upstate Medical University, SYRACUSE, NY
3Suny Upstate Medical University, Syracuse, NY
4SUNY Upstate Medical University, Syracuse, NY
5SUNY Upstate medical university hospital, Syracuse, NY
6SUNY Upstate Medical university Hospital, Syracuse, NY
7SUNY Upstate Medical University Hospital, syracuse, NY
8SUNY Upstate Medical Univeristy Hospital, Syracuse, NY
9SUNY Upstate Medical University, syracuse, NM
10SUNY Upstate Medical University Hospital, Syracuse
11SUNY Upstate Medical University Hospital, Syacuse
12Cleveleand Clinic, Cleveland, OH
13Upstate Cancer Center, Division of Hematology/Oncology, SUNY Upstate Medical University, Syracuse, NY


Sickle cell disease (SCD) is a chronic condition characterized by multiple vaso-occlusive complications. Patients often experience recurrent, severe pain that can be disabling and necessitate opioid treatment. Hospitalization for vaso-occlusive crisis (VOC) is a common occurrence for individuals with SCD. In recent times, the care of hospitalized SCD patients has increasingly shifted from adult hematology specialists to hospitalists. At our institution, we are yet to make this transition, with hospitalists rarely taking over the care of inpatients with SCD. Initially, recommendations to the hospitalist service were provided through informal opinions or formal consultations when requested.

Hospitalists have demonstrated efficient inpatient management; however, some may have knowledge gaps and biases that can influence their interactions with SCD patients. To gain a better understanding of the differences in care practices between hematologists and hospitalists and to identify potential areas for improvement in the care of SCD patients, we conducted a formal comparison of their approaches.

Methods: We performed a single-institution, retrospective review of patients with SCD hospitalized for VOC between January 1, 2014, and September 31, 2022.

Results: Table 1 portrays the significant results.

Conclusion: We observed significant distinctions in the care provided by hematologists and hospitalists to patients admitted for VOC in SCD. Hematologists tended to transfer fewer patients to the intensive care unit compared to hospitalists. On the other hand, hospitalists more frequently sought consultations from the pain service than hematologists. Interestingly, patients under the care of hematologists received longer hours of patient-controlled analgesia for pain management. Additionally, patients managed by hematologists exhibited higher hemoglobin levels at the time of discharge when compared to those treated by hospitalists.

Notably, only 39.8% of patients had a formal hematology consult requested during their hospital stay, indicating a potential need for better collaboration between hematologists and hospitalists. This study emphasizes the importance of enhancing cooperation between these two specialties to elevate the quality of care for patients hospitalized with VOC.

Disclosures: No relevant conflicts of interest to declare.

*signifies non-member of ASH